Mycobacterium aurum bacteremia in an immunocompromised child.

Pediatr Infect Dis J

Department of Pediatrics, College of Medicine, The Ohio State University, Columbus, USA.

Published: December 2003

Mycobacterium aurum was cultured from the Broviac catheter of a 5-year-old child with metastatic Wilms tumor. Removal of the catheter resulted in prompt resolution of the fever and sterilization of the blood culture. This rapidly growing mycobacterium, previously believed to be a commensal, can cause disease in the immunocompromised host.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.inf.0000101787.08603.bbDOI Listing

Publication Analysis

Top Keywords

mycobacterium aurum
8
aurum bacteremia
4
bacteremia immunocompromised
4
immunocompromised child
4
child mycobacterium
4
aurum cultured
4
cultured broviac
4
broviac catheter
4
catheter 5-year-old
4
5-year-old child
4

Similar Publications

The Epiphyte sp. G2112 Produces a Large Diversity of Nobilamide Peptides That Promote Biofilm Formation in Pseudomonads and .

Biomolecules

October 2024

Department of Chemical Ecology/Biological Chemistry, University of Konstanz, Universitätsstraße 10, 78457 Konstanz, Germany.

Article Synopsis
  • Isolate sp. G2112 from cucumber plants produces a variety of bioactive compounds including surfactins, iturins, fengycins, and multiple nobilamide peptides, which were characterized using advanced analytical techniques.
  • Four known and fourteen novel nobilamide peptides were identified, featuring diverse acyl groups and amino acid sequences, and were shown to exist in both linear and cyclic forms.
  • Testing revealed that specific nobilamides (A-3302-B, A-3302-A, and nobilamide J) demonstrated significant antibiotic activity against harmful pathogens, while promoting biofilm formation in various bacteria, highlighting the importance of a common amino acid sequence in this activity.
View Article and Find Full Text PDF

Background: In addition to conventional treatment and modifications in physical activity and diet, alternative strategies have been investigated to manage, prevent, or delay diabetes in humans. In this regard, one strategy has relied on the immunomodulatory properties of mycobacteria, whereby Bacillus Calmette-Guerin, an attenuated live strain of , has been shown to improve glycemic control in patients with diabetes and to alleviate hyperglycemia in selected murine models of diabetes. A novel heat-killed (HK) whole-cell preparation of () is currently under development as a potential food supplement; nevertheless, its potential bioactivity remains largely unknown.

View Article and Find Full Text PDF

The emergence of drug-resistant Mycobacterium tuberculosis strains is a threat to global health necessitating the discovery of novel chemotherapeutic agents. Natural products drug discovery, which previously led to the discovery of rifamycins, is a valuable approach in this endeavor. Against this backdrop, we set out to investigate the in vitro antimycobacterial properties of medicinal plants from Ghana and South Africa, evaluating 36 extracts and their 252 corresponding solid phase extraction (SPE) generated fractions primarily against the non-pathogenic Mycobacterium smegmatis and Mycobacterium aurum species.

View Article and Find Full Text PDF

Non-tuberculosis infections in immunocompromised patients represent a cause for concern, given the increased risks of infection, and limited treatments available. Herein, we report that molecules for binding to the catalytic site of histone deacetylase (HDAC) inhibit its activity, thus increasing the innate immune response against environmental mycobacteria. The action of HDAC inhibitors (iHDACs) was explored in a model of type II pneumocytes and macrophages infection by .

View Article and Find Full Text PDF

Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria.

Sci Rep

March 2024

DST-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, 7505, Cape Town, South Africa.

Mycobacterial pathogens present a significant challenge to disease control efforts globally due to their inherent resistance to multiple antibiotics. The rise of drug-resistant strains of Mycobacterium tuberculosis has prompted an urgent need for innovative therapeutic solutions. One promising way to discover new tuberculosis drugs is by utilizing natural products from the vast biochemical space.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!